Kura Oncology, Inc.
KURA · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $67.5M | $53.9M | +25.2% |
| Operating income | −$304M | −$193M | −57.2% |
| Net income | −$279M | −$174M | −60.2% |
Questions
- What was Kura Oncology's revenue in FY2025?
- $67.5M in FY2025 (Fiscal year ended Dec 31, 2025), +25.2% vs $53.9M a year earlier, per its 10-K filed Mar 2026.
- Was Kura Oncology profitable in FY2025?
- No: net income was −$279M and operating income −$304M in FY2025.